钠－葡萄糖共转运蛋白2抑制剂对急性心肌梗死患者经皮冠状动脉介入治疗术后主要不良心血管事件发生的影响：一项Meta分析
异质性,死亡率,入院
【中图分类号】 R542.22 【文献标识码】 AD0I： 10.12114/j.issn.1007-9572.2024.0470Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Major Adverse Cardiovascular Events Following PCI in Patients with Acute Myocardial Infarction：a Meta-analysis
DENG Yifan1，2，3，HE Shenghu1，3，ZHANG Jing1，2，3，4*，ZHU Li2 ，5*
1.DepartmentofCardiovascular Medicine，NorthernJiangsu People's Hospital，Yangzhou225oo1，Chin
2.Medical Collegeof Yangzhou University，Yangzhou 225oo1，China
3.NorthernJiangsu People'sHospitalAffiliated toYangzhou University，Yangzhou225ool，China
4.The Yangzhou Clinical Medical College of Xuzhou Medical University，Yangzhou 225Oo1，China
5.Department ofCardiovascular Medicine，Taizhou People's Hospital，Taizhou 2253oo，China
Corresponding authors：ZHANGJing，Chiefphysician； E -mail：zhangjingyjs@163.com
ZHULi，Chief physician/Doctoral supervisor； E -mail：tzheart@126.com
【Abstract】BackgroundSodium-glucose cotransporter 2 inhibitors(SGLT2i)have been proven to effectively improve the prognosis of patients with heart failure，chronic kidneydisease，and diabetes in thecontextof cardiovascularrenal-ndocrinecordinatedmanagement.However ......
您现在查看是摘要页，全文长 17948 字符。